95 related articles for article (PubMed ID: 17217690)
1. [Elevated serum secretory type II phospholipase A2 in patients with coronary heart disease].
Yu L; Jiang WB; Fu GS; Qin GM; Wang JH; Huang ZQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):812-5. PubMed ID: 17217690
[TBL] [Abstract][Full Text] [Related]
2. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.
Kugiyama K; Ota Y; Sugiyama S; Kawano H; Doi H; Soejima H; Miyamoto S; Ogawa H; Takazoe K; Yasue H
Am J Cardiol; 2000 Oct; 86(7):718-22. PubMed ID: 11018189
[TBL] [Abstract][Full Text] [Related]
4. Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
Mallat Z; Benessiano J; Simon T; Ederhy S; Sebella-Arguelles C; Cohen A; Huart V; Wareham NJ; Luben R; Khaw KT; Tedgui A; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1177-83. PubMed ID: 17303774
[TBL] [Abstract][Full Text] [Related]
5. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
[TBL] [Abstract][Full Text] [Related]
7. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
Mallat Z; Steg PG; Benessiano J; Tanguy ML; Fox KA; Collet JP; Dabbous OH; Henry P; Carruthers KF; Dauphin A; Arguelles CS; Masliah J; Hugel B; Montalescot G; Freyssinet JM; Asselain B; Tedgui A
J Am Coll Cardiol; 2005 Oct; 46(7):1249-57. PubMed ID: 16198839
[TBL] [Abstract][Full Text] [Related]
8. [Serum level of secretory phospholipase A2 (sPLA2) as a predictor of restenosis after coronary angioplasty].
Korotaeva AA; Provatorov SI; Samoĭlova EV; Kaminnyĭ AI; Sumarokov AB; Pirkova AA; Samko AN; Prokazova NV
Ter Arkh; 2002; 74(4):12-5. PubMed ID: 12043230
[TBL] [Abstract][Full Text] [Related]
9. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
Korotaeva AA; Samoilova EV; Kaminny AI; Pirkova AA; Resink TJ; Erne P; Prokazova NV; Tkachuk VA; Chazov EI
Mol Cell Biochem; 2005 Feb; 270(1-2):107-13. PubMed ID: 15792359
[TBL] [Abstract][Full Text] [Related]
10. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
[TBL] [Abstract][Full Text] [Related]
11. Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.
Wootton PT; Arora NL; Drenos F; Thompson SR; Cooper JA; Stephens JW; Hurel SJ; Hurt-Camejo E; Wiklund O; Humphries SE; Talmud PJ
Hum Mol Genet; 2007 Jun; 16(12):1437-44. PubMed ID: 17545304
[TBL] [Abstract][Full Text] [Related]
12. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
13. Stored red blood cells selectively activate human neutrophils to release IL-8 and secretory PLA2.
Zallen G; Moore EE; Ciesla DJ; Brown M; Biffl WL; Silliman CC
Shock; 2000 Jan; 13(1):29-33. PubMed ID: 10638666
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
[TBL] [Abstract][Full Text] [Related]
15. Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein.
Santoso A; Kaniawati M; Bakri S; Yusuf I
Int J Angiol; 2013 Mar; 22(1):49-54. PubMed ID: 24436584
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response.
Stam TC; Swaak AJ; Kruit WH; Stoter G; Eggermont AM
Eur J Clin Invest; 2000 Apr; 30(4):336-43. PubMed ID: 10759883
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between Chinese medicine syndrome and serum level of high-sensitivity C-reactive protein in patients with stable coronary heart disease].
Zheng F; Qu D; Xu H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jun; 29(6):485-8. PubMed ID: 19702076
[TBL] [Abstract][Full Text] [Related]
18. The role of secretory phospholipase A2 in acute chest syndrome.
Kuypers FA; Styles LA
Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):87-94. PubMed ID: 15040432
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent.
Azar M; Valentin E; Badaoui G; Kassab R; Sarkis A; Azar RR
Am J Cardiol; 2011 Jun; 107(11):1571-4. PubMed ID: 21439529
[TBL] [Abstract][Full Text] [Related]
20. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
